205 related articles for article (PubMed ID: 11330612)
1. Effects of finasteride on size of the prostate gland and semen quality in dogs with benign prostatic hypertrophy.
Sirinarumitr K; Johnston SD; Kustritz MV; Johnston GR; Sarkar DK; Memon MA
J Am Vet Med Assoc; 2001 Apr; 218(8):1275-80. PubMed ID: 11330612
[TBL] [Abstract][Full Text] [Related]
2. Changes in the Serum Prostatic Biomarkers During the Treatment of Benign Prostatic Hyperplasia with a 5alpha-reductase Inhibitor: Finasteride.
Golchin-Rad K; Mogheiseh A; Nazifi S; Ahrari Khafi MS; Derakhshandeh N; Abbaszadeh-Hasiri M
Top Companion Anim Med; 2020 Mar; 38():100405. PubMed ID: 32115076
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Habib FK; Ross M; Tate R; Chisholm GD
Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
[TBL] [Abstract][Full Text] [Related]
4. Finasteride-induced prostatic involution by apoptosis in dogs with benign prostatic hypertrophy.
Sirinarumitr K; Sirinarumitr T; Johnston SD; Sarkar DK; Kustritz MV
Am J Vet Res; 2002 Apr; 63(4):495-8. PubMed ID: 11939309
[TBL] [Abstract][Full Text] [Related]
5. Effects of an extract of Serenoa repens on dogs with hyperplasia of the prostate gland.
Barsanti JA; Finco DR; Mahaffey MM; Fayrer-Hosken RA; Crowell WA; Thompson FN; Shotts EB
Am J Vet Res; 2000 Aug; 61(8):880-5. PubMed ID: 10951976
[TBL] [Abstract][Full Text] [Related]
6. Effect of finasteride (Proscar MSD) on seminal composition, prostate function and fertility in male dogs.
Iguer-Ouada M; Verstegen JP
J Reprod Fertil Suppl; 1997; 51():139-49. PubMed ID: 9404280
[TBL] [Abstract][Full Text] [Related]
7. Reproductive and endocrinological effects of Benign Prostatic Hyperplasia and finasteride therapy in dogs.
Angrimani DSR; Brito MM; Rui BR; Nichi M; Vannucchi CI
Sci Rep; 2020 Sep; 10(1):14834. PubMed ID: 32908208
[TBL] [Abstract][Full Text] [Related]
8. Endocrine, prostatic vascular, and proapoptotic changes in dogs with benign prostatic hyperplasia treated medically or surgically.
Lima CB; Angrimani DSR; Flores RB; Vannucchi CI
Domest Anim Endocrinol; 2021 Apr; 75():106601. PubMed ID: 33333452
[TBL] [Abstract][Full Text] [Related]
9. Effects of benign prostatic hyperplasia and finasteride therapy on prostatic blood flow in dogs.
Angrimani DSR; Silvestrini GR; Brito MM; Abreu RA; Almeida LL; Vannucchi CI
Theriogenology; 2018 Jul; 114():103-108. PubMed ID: 29605575
[TBL] [Abstract][Full Text] [Related]
10. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
[TBL] [Abstract][Full Text] [Related]
11. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Bartsch G; Rittmaster RS; Klocker H
Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
[TBL] [Abstract][Full Text] [Related]
12. Effects of competitive and noncompetitive 5α-reductase inhibitors on serum and intra-prostatic androgens in beagle dogs.
Zhao XF; Yang Y; Wang W; Qiu Z; Zhang P; Wang B
Chin Med J (Engl); 2013 Feb; 126(4):711-5. PubMed ID: 23422194
[TBL] [Abstract][Full Text] [Related]
13. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen.
Schwartz JI; Tanaka WK; Wang DZ; Ebel DL; Geissler LA; Dallob A; Hafkin B; Gertz BJ
J Clin Endocrinol Metab; 1997 May; 82(5):1373-7. PubMed ID: 9141518
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of new specific azasteroid inhibitors of steroid 5 alpha-reductase on canine hyperplastic prostate: suppression of prostatic DHT correlated with prostate regression.
Cohen SM; Werrmann JG; Rasmusson GH; Tanaka WK; Malatesta PF; Prahalada S; Jacobs JG; Harris G; Nett TM
Prostate; 1995 Feb; 26(2):55-71. PubMed ID: 7531846
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging of the efficacy of specific inhibition of 5 alpha-reductase in canine spontaneous benign prostatic hyperplasia.
Cohen SM; Taber KH; Malatesta PF; Shpungin J; Berman C; Carlin JR; Werrmann JG; Prahalada S; Bryan RN; Cordes EH
Magn Reson Med; 1991 Sep; 21(1):55-70. PubMed ID: 1719333
[TBL] [Abstract][Full Text] [Related]
16. Determination of concentrations of sex steroids in blood plasma and semen of male dogs treated with delmadinone acetate or finasteride.
Lange K; Cordes EK; Hoppen HO; Günzel-Apel AR
J Reprod Fertil Suppl; 2001; 57():83-91. PubMed ID: 11787194
[TBL] [Abstract][Full Text] [Related]
17. Effect of finasteride on serum concentrations of dihydrotestosterone and testosterone in three clinically normal sexually intact adult male dogs.
Kamolpatana K; Johnston SD; Hardy SK; Castner S
Am J Vet Res; 1998 Jun; 59(6):762-4. PubMed ID: 9622748
[TBL] [Abstract][Full Text] [Related]
18. Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. The Finasteride Study Group.
Prostate; 1993; 22(4):291-9. PubMed ID: 7684524
[TBL] [Abstract][Full Text] [Related]
19. Effect of osaterone acetate administration on prostatic regression rate, peripheral blood hormone levels and semen quality in dogs with benign prostatic hypertrophy.
Tsutsui T; Hori T; Shimizu M; Tatsuzawa C; Kawakami E
J Vet Med Sci; 2001 Apr; 63(4):453-6. PubMed ID: 11346183
[TBL] [Abstract][Full Text] [Related]
20. The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.
Gormley GJ; Stoner E; Bruskewitz RC; Imperato-McGinley J; Walsh PC; McConnell JD; Andriole GL; Geller J; Bracken BR; Tenover JS
N Engl J Med; 1992 Oct; 327(17):1185-91. PubMed ID: 1383816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
